OUR VISION IS TO REDUCE ILLNESS AND DEATH ASSOCIATED WITH FUNGAL DISEASES WORLDWIDE.

News

Keep up to date with the latest news items from GAFFI.

Fungal disease experts call for antigen detection techniques to be implemented for AIDS globally based on extensive Guatemalan experience

Posted .

Research paper  reveals non-culture testing for histoplasmosis, cryptococcosis and TB in AIDS is far more sensitive than microscopy or culture In a research paper published today in the prestigious journal AIDS, Narda Medina and colleagues from the Global Action Fund for Fungal Infections (GAFFI) and Asociacion de Salud Integral, Guatemala City evaluated the diagnostic performance… Read more »

Read more >

Over a million people in China suffer from life-threatening aspergillosis

Posted .

Almost no one survives invasive aspergillosis without antifungal therapy. Thought to affect up to 300,000 each year across the world, a new research paper from Fudan University in Shanghai, China and the Global Action Fund for Fungal Infections (GAFFI) now estimates that 1,179,000 people suffer from invasive aspergillosis in China alone. This estimate excludes COVID-19… Read more »

Read more >

GAFFI calls together experts in Lima to formulate new thinking on fungal disease management in Latin America

Posted .

July 1st 2020 15:00 BST (GMT+1) For Spanish version click here Briefing webinar: https://us02web.zoom.us/j/82914301088 For further details of the briefing visit ECMM website September 3-5th over 60 fungal disease experts from Argentina, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay and Venezuela convened in… Read more »

Read more >

GAFFI convoca a un grupo de expertos en Lima para afrontar la enfermedad fúngica en Latinoamérica

Posted .

July 1st 2020 15:00 BST (GMT+1) For English version click here Briefing webinar: https://us02web.zoom.us/j/82914301088 Para más detalles de la sesión informativa, visite el sitio web de ECMM Del 3 al 5 de septiembre de 2019, más de 60 expertos en enfermedades fúngicas de Argentina, Brasil, Chile, Colombia, Costa Rica, Cuba, República Dominicana, Ecuador, El Salvador,… Read more »

Read more >

PAHO issues guidelines on disseminated histoplasmosis in HIV/AIDS

Posted .

Disseminated histoplasmosis is under-diagnosed and as a result, is the cause of death in up to 20% of people dying of AIDS. Antigen detection in serum or urine is more sensitive and faster than conventional diagnosis, usually based on culture, or histopathology of skin lesions or bone marrow.  Today the Pan American Health Organization has… Read more »

Read more >

GAFFI Ambassadors shine light on decades of mycetoma in Senegal and Uganda

Posted .

Mycetoma is a chronic granulomatous deep mycosis that causes debilitating lesions, caused by fungal or bacterial implantation through the skin. In Uganda, Richard Kwizera, Dr Felix Bongomin and colleagues in Kampala published a 69 year retrospective study of all biopsy reports produced by the Pathology Reference Laboratory at Makerere University from 1950 to 2019 (249… Read more »

Read more >

How common is chronic pulmonary histoplasmosis? No one knows, but it is likely global and grossly under-diagnosed

Posted .

First described in in 1948 and acknowledged as a separate clinical entity in 1953, many patients with chronic pulmonary histoplasmosis (CPH) languished in US tuberculosis sanatoriums, until picked out in the 1950’s. In one sanatorium in Missouri, 7.2% of ‘TB patients’ actually had CPH. In a review just published in Open Forum Infectious Diseases, Jacob… Read more »

Read more >

On World Tuberculosis Day, remember TB-like fungal infections and co-infection of TB and Aspergillus

Posted .

  Several lung fungal infections can be mistaken for TB – histoplasmosis, aspergillosis, coccidioidomycosis and paracoccidioidomycosis.  Antibody testing and fungal culture of sputum are the means of establishing the diagnosis. The number of incident cases of these fungal infections varies substantially by region and country and the rate of misdiagnosis of TB-like fungal infections is not… Read more »

Read more >

Neglected, market failures, public health failures

Posted .

  Writing in PLoS Neglected Tropical Diseases, Marcio Rodrigues and Joshua Nosanchuk highlight the numerous reasons why fungal diseases are so neglected. They point to a science failure – including inadequate funding. They detail research funding for different diseases by numbers of deaths: malaria $1,315 , tuberculosis $334, diarrhoeal diseases $276, compared with $31 for… Read more »

Read more >